跳至主要内容
临床试验/ISRCTN92093279
ISRCTN92093279
已完成
未知

Simvastatin and severe Sepsis: a randomised controlled Trial

Oxford Radcliffe Hospitals NHS Trust (UK)0 个研究点目标入组 104 人2005年9月1日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Severe sepsis
发起方
Oxford Radcliffe Hospitals NHS Trust (UK)
入组人数
104
状态
已完成
最后更新
8年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2005年9月1日
结束日期
待定
最后更新
8年前
研究类型
Interventional
性别
All

研究者

发起方
Oxford Radcliffe Hospitals NHS Trust (UK)

入排标准

入选标准

  • Patients eligible for inclusion:
  • 1\. Those admitted to the Adult Intensive Care Unit at John Radcliffe Hospital, Royal Sussex County Hospital and the Royal Berkshire Hospital (last two centres added 10/10/2007\)
  • 2\. Severe sepsis or develop severe sepsis whilst in intensive care
  • Patients must be randomised and receive the first dose of simvastatin within 24 hours of first organ dysfunction to be included in the study.

排除标准

  • Patients will be excluded from the trial if they:
  • 1\. Are receiving simvastatin or another statin prior to admission
  • 2\. Refuse consent or their relatives refuse assent
  • 3\. Are less than 16 years of age
  • 4\. Are included in another interventional study
  • 5\. Have a known adverse reaction to statins
  • 6\. Have an indication or contraindication to treatment with a statin, according to the treating physician
  • 7\. Are unable to receive enteral medications
  • 8\. Are receiving drugs known to interact with simvastatin
  • 9\. Have active liver disease

结局指标

主要结局

未指定

相似试验